• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自膨式金属食管内支架,带膜和不带膜:30例病例回顾

Self-expanding metal oesophageal endoprostheses, covered and uncovered: a review of 30 cases.

作者信息

Hills K S, Chopra K B, Pal A, Westaby D

机构信息

Department of Gastroenterology, Chelsea and Westminster Hospital, London, UK.

出版信息

Eur J Gastroenterol Hepatol. 1998 May;10(5):371-4. doi: 10.1097/00042737-199805000-00003.

DOI:10.1097/00042737-199805000-00003
PMID:9619381
Abstract

OBJECTIVE

Oesophageal self-expanding metal endoprostheses (SEMS, or stents) are recognized as a safe means of palliating dysphagia caused by malignancy. Stent designs that have covered or uncovered walls are now available. The purpose of this study was to compare the outcome of use of these two designs.

DESIGN

Thirty consecutive cases were reviewed. All the patients had been referred over a period of 25 months for palliation of dysphagia caused by malignant obstruction. Either a covered or an uncovered stent was placed in each patient. Palliation of dysphagia, 30 day mortality, mean survival time, and the number of endoscopic re-interventions required, were assessed.

RESULTS

Uncovered Ultraflex stents were used in 14 patients, and Schneider Wallstents were used in 16 patients. Dysphagia improved by one grade or more in 69% of patients. The 30 day mortality was 27%, with an overall mean survival time of 99 days. There was no significant difference between the two groups for these three parameters. Ten patients needed a total of 28 repeat endoscopic procedures to maintain stent patency, with overall rates for each group of 1.64 procedures per patient, for uncovered stents, compared with 0.31 for covered stents (significant at the P < 0.05 level). The number of repeat procedures increased with survival time.

CONCLUSION

The use of covered self-expanding metal oesophageal endoprostheses is associated with a significant reduction in the need for endoscopic reintervention after stent placement.

摘要

目的

食管自膨式金属内支架(SEMS,或支架)被认为是缓解恶性肿瘤所致吞咽困难的一种安全方法。现在有带覆膜和不带覆膜的支架设计。本研究的目的是比较这两种设计的使用效果。

设计

回顾了连续30例病例。所有患者在25个月的时间里因恶性梗阻所致吞咽困难而被转诊。为每位患者置入带覆膜或不带覆膜的支架。评估吞咽困难的缓解情况、30天死亡率、平均生存时间以及所需内镜再干预的次数。

结果

14例患者使用了不带覆膜的Ultraflex支架,16例患者使用了施奈德Wallstent支架。69%的患者吞咽困难改善一级或更多。30天死亡率为27%,总体平均生存时间为99天。这三个参数在两组之间没有显著差异。10例患者共需要28次重复内镜检查以维持支架通畅,不带覆膜支架组每位患者的总体检查率为1.64次,而带覆膜支架组为0.31次(P<0.05水平有显著差异)。重复检查的次数随生存时间增加。

结论

使用带覆膜的自膨式金属食管内支架与支架置入后内镜再干预需求的显著减少相关。

相似文献

1
Self-expanding metal oesophageal endoprostheses, covered and uncovered: a review of 30 cases.自膨式金属食管内支架,带膜和不带膜:30例病例回顾
Eur J Gastroenterol Hepatol. 1998 May;10(5):371-4. doi: 10.1097/00042737-199805000-00003.
2
Self-expanding metal oesophageal endoprostheses: which is best?自膨式金属食管内支架:哪种最佳?
Eur J Gastroenterol Hepatol. 1998 May;10(5):363-5. doi: 10.1097/00042737-199805000-00001.
3
Endoscopic palliation of unresectable malignant oesophageal strictures with self-expanding metal stents: comparing Ultraflex and Esophacoil stents.使用自膨式金属支架对不可切除的恶性食管狭窄进行内镜下姑息治疗:比较Ultraflex支架和Esophacoil支架
Dig Liver Dis. 2002 May;34(5):356-63. doi: 10.1016/s1590-8658(02)80130-x.
4
[Self-expanding metal stents for palliation of malignant oesophageal obstruction].用于缓解恶性食管梗阻的自膨式金属支架
Magy Seb. 2009 Apr;62(2):59-66. doi: 10.1556/MaSeb.62.2009.2.2.
5
A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia.自膨式塑料支架与部分覆膜自膨式金属支架用于缓解恶性食管吞咽困难的随机前瞻性比较
Am J Gastroenterol. 2007 Dec;102(12):2667-77. doi: 10.1111/j.1572-0241.2007.01565.x.
6
[Our experience with the use of a plastic prosthesis and self-expanding stents in the palliative treatment of malignant neoplastic stenoses of the esophagus and cardia. Comparative analysis of results].[我们使用塑料假体和自膨式支架姑息治疗食管和贲门恶性肿瘤狭窄的经验。结果的比较分析]
Chir Ital. 2002 May-Jun;54(3):341-50.
7
A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction.一项关于覆膜可扩张金属支架缓解胃食管交界处恶性食管梗阻的前瞻性、随机、对照试验。
Am J Gastroenterol. 2001 Jun;96(6):1791-6. doi: 10.1111/j.1572-0241.2001.03923.x.
8
A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma.Flamingo Wallstent支架与Ultraflex支架用于缓解食管下段癌所致吞咽困难的随机前瞻性比较。
Gut. 2003 Jul;52(7):922-6. doi: 10.1136/gut.52.7.922.
9
Fluoroscopically guided insertion of self-expandable metal esophageal stents for palliative treatment of patients with malignant stenosis of esophagus and cardia: comparison of uncovered and covered stent types.透视引导下自膨式金属食管支架置入术治疗食管及贲门恶性狭窄患者的姑息治疗:裸支架与覆膜支架类型的比较
Dis Esophagus. 2005;18(4):230-8. doi: 10.1111/j.1442-2050.2005.00484.x.
10
Management of inoperable malignant oesophageal strictures with fully covered WallFlex(®) stent: a multicentre prospective study.使用全覆膜WallFlex(®)支架治疗不可手术切除的恶性食管狭窄:一项多中心前瞻性研究。
Dig Liver Dis. 2014 Dec;46(12):1093-8. doi: 10.1016/j.dld.2014.08.037. Epub 2014 Sep 26.

引用本文的文献

1
Evidence-based choice of esophageal stent for the palliative management of malignant dysphagia.
World J Surg. 2008 Sep;32(9):1996-2009. doi: 10.1007/s00268-008-9654-1.
2
Delayed complications after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate.自膨式支架置入治疗恶性食管梗阻后的延迟并发症:治疗策略与生存率
Dig Dis Sci. 2008 Feb;53(2):334-40. doi: 10.1007/s10620-007-9862-9. Epub 2007 Jun 28.
3
A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma.Flamingo Wallstent支架与Ultraflex支架用于缓解食管下段癌所致吞咽困难的随机前瞻性比较。
Gut. 2003 Jul;52(7):922-6. doi: 10.1136/gut.52.7.922.